Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Tree MATA in Subjects Allergic to Tree Pollen

NCT00113750 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT00113750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00113750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Tree MATA in Subjects Allergic to Tree Pollen
Lead sponsor
Allergy Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
December 31, 2005
Enrollment
70
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

type i hypersensitivity